Lv11
70 积分 2024-11-29 加入
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
5小时前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
21天前
已完结
Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial
21天前
已完结
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
21天前
已完结
A commentary on “comparison of surgical outcomes and learning curve for robotic versus laparoscopic living donor hepatectomy: a retrospective cohort study” (int j surg 2022;108:107000)
1个月前
已完结
Laparoscopic Resection of the Middle Bile Duct for Cholangiocarcinoma (with Video)
1个月前
已完结
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis
1个月前
已完结
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
3个月前
已完结
Neoadjuvant therapy with triple therapy for Centrally located hepatocellular carcinoma
3个月前
已关闭
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
3个月前
已完结
皖公网安备34019202002308
